In 2018, Stephen Aselage earned $932.78K in total compensation at Travere Therapeutics, Inc., including $593.33K salary and $331.20K bonus. Most recently acquired 6,820 shares in Jun 2024. Currently holds stock worth $6.38M. Has donated $1.09M in stock to charitable causes. Led Travere Therapeutics, Inc. as CEO for 4 years.
Compensation History
Annual executive compensation data for Stephen Aselage, including salary, bonuses, and stock awards.
Year
2018
Total Compensation
$932.78K
Salary
$593.33K
Bonus
$331.20K
Other
$8.25K
Salary
$593.33KBoard Justification
The compensation philosophy is designed to attract, retain, and motivate talented executives, aligning their interests with those of the shareholders through performance-based incentives.
Bonus
$331.20KBoard Justification
Performance-based incentive payment awarded for 2018 performance, based on the achievement of corporate performance goals at the 92% level.
Other Compensation
$8.25KBoard Justification
Represents the Company’s 401(k) match for the year 2018.
Restricted Stock
Board Justification
No vested stock was reported for 2018 as the focus is on cash compensation and performance-based bonuses.
Performance Metrics
The performance metrics included total revenues, progress on clinical trials, and other operational objectives.
Stephen Aselage
Ex-CEO of Travere Therapeutics, Inc.
Education
B.S. in Biology from the University of Notre Dame
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
Born
June 15, 1951 - 74 years ago
CEO of Travere Therapeutics, Inc. for
4 years 3 months (Sep 2014 - Jan 2019)
Previous Experience
Executive Vice President and Chief Business Officer at BioMarin
Holdings
Track Stephen Aselage's stock holdings and portfolio value over time.
Total Stock Sold
$12.53M
$7.59M
208,380 BMRN shares
$4.94M
181,188 TVTX shares
What if they kept their stock?
If Stephen Aselage didn't sell their stock, today they would have:
Extra BMRN208,380 shares worth $11.13M and TVTX181,188 shares worth $6.34M.
This is 39.42% and $4.94M more than what they got when they sold the stock.
Charitable Transactions
31,000 shares
TVTX
Recent Charitable Transactions
28,000 shares
TVTX
Nov 1, 2021
Charity
3,000 shares
TVTX
Dec 2, 2020
Charity
Insider Trading
Stephen Aselage's recent stock transactions, purchases, and sales filed with the SEC.
6,820 shares
BCRX
Jun 12, 2024
Received
$16.00K
BCRX at $6.40/share
May 24, 2024
Purchase
16,745 shares
BCRX
Jun 13, 2023
Received
12,866 shares
BCRX
Jun 7, 2022
Received
$5.30K
BCRX at $9.31/share
May 31, 2022
Received
$56.46K
TVTX at $21.92/share
May 11, 2022
Sale
$5.00K
BCRX at $16.61/share
Feb 28, 2022
Received
$4.99K
BCRX at $12.06/share
Nov 30, 2021
Received
$934.60K
TVTX at $29.39/share
Nov 16, 2021
Sale
$262.30K
TVTX at $26.23/share
Nov 5, 2021
Sale
Rivals
Compare Stephen Aselage with competitor CEOs and industry peers.